ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE IN LIVER DISEASE PATIENTS REVIEW ARTICLE

Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 12

Abstract

Health-related quality of life has become an important outcome measure for overall assessment of patients with liver disease; it provides detail about the nature of disease and extent of its effects on individuals. Actual purpose of this study is to access the facets of health-related quality of life in chronic liver diseases throughout their spectrum of severity. Liver diseases are a health and social problem globally and its burden is expected to increase with passage of time. A number of different studies have shown a clear reduction in the quality of life of liver-disease patients. Patients with liver disease often suffer from unspecific symptoms and report severe impairment in the quality of life. Hepatitis C and B is major cause of liver disease globally and it leads to cirrhosis. Majority of chronic hepatitis C patients are without symptoms, many extra-hepatic symptoms, such as tiredness, anorexia, myalgia, arthralgia, touchiness and headaches, can lead to impair health-related quality of life. Hepatitis B virus infection has long been the foremost cause of chronic liver disease including liver cancer and cirrhosis. Patients of hepatitis B suffer from depression, fatigue, pain in joints, severity of disease and sadness which will affect their health-related quality of life. Cirrhosis is end-stage liver disease, in which the liver progress scarring as a result of long-term hepatitis B and C. Cirrhotic patients has worst health-related quality of life due to complications of cirrhosis such as (hepatic encephalopathy, ascites, spontaneous bacterial peritonitis, and recurrent variceal hemorrhages). Quality of life can be assessed by means of Well-developed liver disease-specific health-related quality of life instruments which are the Hepatitis Quality of Life Questionnaire (HQLQ), the Chronic Liver Disease Questionnaire (CLDQ), the Liver Disease Quality Of Life Questionnaire (LDQOL), and the Liver Disease Symptom Index 2.0 (LDSI 2.0).Most widely used questionnaire is Chronic Liver Disease Questionnaire (CLDQ).

Authors and Affiliations

Neelam Liaqat

Keywords

Related Articles

EFFECT OF GLUCOSE CONCENTRATION ON THE SPINAL ANESTHESIA OF 0.4% ENANTIOMERIC EXCESS LEVOBUPIVACAINE (S75:R25)

Background: Baricity is one of the most important factors to influence the characteristics of distribution of the local anesthetic and hence success and spread of the blockade. Bupivacaine is rendered hyperbaric by addin...

PHYSICAL REHABILITATION PROCEDURES AND HOLISTIC APPROACHES TO THE TREATMENT OF SOME NEURODEGENERATIVE DISEASES

Neurodegenerative disease is an umbrella term for a wide range of disorders with one common aspect – they are all characterised by a progressive loss of neurons in the brain (cerebrum) and the spinal cord, as a result of...

REPLACEMENT OF SOME PLANT PROTEIN SOURCES BY SUNFLOWER CAKE WITH OR WITHOUT ENZYME ON BROILER DIETS

Total of two hundred and ten unsexed commercial chicks were used in this experiment to evaluate the effect of feeding different levels of sunflower meal (SFM) with and without dietary enzyme on performance of broiler chi...

UNANI AND WESTERN PERSPECTIVE OF DA’- US- SADAF (PSORIASIS): A REVIEW

Da‟- us- Sadaf (Psoriasis) is a chronic, non communicable, painful, disfiguring and disabling disease for which there is no cure and with great negative impact on patient‟s quality of life. Social exclusion, discriminati...

SURGICAL MANAGEMENT OF PAGET’S DISEASE OF THE VULVA: A CASE REPORT

Extra-mammary Paget disease (EMPD) is one of the rare neoplastic conditions of the skin that accounts for less than 1% of the vulvar malignancies. The condition typically presents as a red, velvety, pruritic skin rash of...

Download PDF file
  • EP ID EP620446
  • DOI -
  • Views 167
  • Downloads 0

How To Cite

Neelam Liaqat (2017). ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE IN LIVER DISEASE PATIENTS REVIEW ARTICLE. WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE, 6(12), 200-213. https://www.europub.co.uk/articles/-A-620446